|Sponsor||Rep. Gordon, Bart|
|Date||September 22, 2010 (111th Congress, 2nd Session)|
|Staff Contact||Brian McManus|
H.R. 2923 is expected to be considered on the House floor on Wednesday, September 22, 2010, under suspension of the rules, requiring a two-thirds majority vote for passage. Rep. Gordon (D-TN) introduced H.R. 2923 on June 17, 2009, and it was referred to the Committee on Energy and Commerce. On July 28, 2010, the committee reported the bill by voice vote.
H.R. 2923 would require retail businesses that sell certain pharmaceuticals at the retail level or through the mail to submit a self-certification document to the Attorney General. The self-certification document would include a statement saying the seller understands the requirements and agrees to comply with them. The Attorney General would make the list available on the Drug Enforcement Administration (DEA) website. Also, H.R. 2923 would prohibit distributors of certain pharmaceuticals from selling products to persons who have not registered or self-certified with the DEA. Lastly, violators would be subject to civil and criminal fines.
Civil fines are recorded as revenue. Criminal fines are recorded as revenue but are deposited in the Crime Victims Fund and then spent. Therefore, H.R. 2923 affects revenue and spending, and pay-go applies. However, the CBO estimates that any budget impact would not be significant in any year.